<SEC-DOCUMENT>0001209191-23-038443-index.html : 20230620
<SEC-HEADER>0001209191-23-038443.hdr.sgml : 20230620
<ACCEPTANCE-DATETIME>20230620164809
ACCESSION NUMBER:		0001209191-23-038443
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230615
FILED AS OF DATE:		20230620
DATE AS OF CHANGE:		20230620

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Pellizzari Christine A
		CENTRAL INDEX KEY:			0001127430

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35890
		FILM NUMBER:		231025907

	MAIL ADDRESS:	
		STREET 1:		10 FINDERNE AVENUE
		CITY:			BRIDGEWATER
		STATE:			NJ
		ZIP:			08807

	FORMER NAME:	
		FORMER CONFORMED NAME:	PELLIZZARI CHRISTINE A
		DATE OF NAME CHANGE:	20001030

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tempest Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001544227
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				451472564
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		2000 SIERRA POINT PARKWAY
		STREET 2:		SUITE 400
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005
		BUSINESS PHONE:		415-798-8589

	MAIL ADDRESS:	
		STREET 1:		2000 SIERRA POINT PARKWAY
		STREET 2:		SUITE 400
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Millendo Therapeutics, Inc.
		DATE OF NAME CHANGE:	20181207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OvaScience, Inc.
		DATE OF NAME CHANGE:	20120308
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
Document 1 - file: doc4.html

Document 1 - RAW XML: doc4.xml

</DOCUMENT>
</SEC-DOCUMENT>